Clinical Trial

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Name: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD — clinical trial record (NCT05711940)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Protocol Amendment History 1 change

notable Primary completion moved earlier: 2026-02 -> 2025-11-13 2026-08-11

Trial Details

NCT Number	NCT05711940
Lead Sponsor	COMPASS Pathways
Conditions	Treatment Resistant Depression
Enrollment	572 participants
Start Date	2023-02-14
Primary Completion	2025-11-13 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-10